ESC 365 - The risk of sudden cardiac death and use of SGLT2 inhibitors in patients with heart failure: a meta-analysis of pivotal randomized controlled trials including 17,911 patients

HFA Premium Access

The risk of sudden cardiac death and use of SGLT2 inhibitors in patients with heart failure: a meta-analysis of pivotal randomized controlled trials including 17,911 patients

Session: ePosters in interventional cardiology and pharmacology

Topic: Cardiovascular Pharmacotherapy

Speaker: Doctor M. Kumric (Split, HR)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Marko Kumric

University of Split School of Medicine, Split (Croatia)

0 follower

4 more presentations in this session

Experience of arterial hypertension management in a women with aortic coarctation diagnosed during pregnancy

Speaker: Doctor I. Ditkivskyy (Kyiv, UA)

Accessory pathway ablation in the era of electroanatomic mapping systems and contact force ablation catheters

Speaker: Ms C. Marques (Porto, PT)

Driveline infection in patients with left ventricular assist devices implanted as destination therapy.

Speaker: Doctor G. Wasilewski (Krakow, PL)

Prescription patterns of disease modyfing drugs of patients admitted to an advanced heart failure unit

Speaker: Doctor J. Mesquita Guimaraes (Coimbra, PT)

Access the full session

ePosters in interventional cardiology and pharmacology

Speakers: Doctor M. Kumric, Doctor I. Ditkivskyy, Ms C. Marques, Doctor G. Wasilewski, Doctor J. Mesquita Guimaraes

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources